Purpose of Review

To highlight current evidence supporting the prescription of cognitive behavioral therapy (CBT) as part of first‐line preventive treatment for children and adolescents with headache and discuss a research strategy aimed at: (1) understanding how and why CBT works, and (2) developing effective and efficient approaches for integrating CBT into headache specialty, neurology, and primary care settings.… Read More...

Objective

To investigate the association between congenital heart defects (CHDs) and migraine and evaluate the efficacy of transcatheter defect closure from a new perspective.

Methods

The patients with CHDs who underwent transcatheter defect closure were screened in the medical database of Chinese PLA General Hospital from January 2006 to January 2017.… Read More...

Background

The current study aimed to describe the impact of parental migraine on adolescent children (aged 11–17) living at home with a parent with migraine.

Aim

Many drug classes are prescribed for migraine treatment, but all have limitations. Recently, calcitonin gene‐related peptide (CGRP) activity has shown a significant promise as a target for preventive therapy.… Read More...

Objective

The aim of the prospective longitudinal service evaluation was to reveal the incidence of persistent headache at 18 months following accidental dural puncture with a 16‐gauge Tuohy needle. This followed an observation that a subset of female patients was presenting to the local pain medicine clinic with persistent headache following an accidental dural puncture.… Read More...

Cephalalgia, Ahead of Print.

Objective

To assess the acute treatment of pregnant women presenting to a hospital with migraine.

Background

Migraine is a common problem in pregnancy; however, migraine treatment is challenging in pregnant women for fears of medication teratogenicity and lack of data in this population.… Read More...

Objective

To briefly update and correct the available data on anti‐calcitonin gene‐related peptide (CGRP) therapies for headache since the American Headache Society 60th Scientific Meeting, San Francisco, June 2018.

Background

CGRP is a target for primary headache therapies.

Methods

The author briefly reviews the new data and publications on gepants and anti‐CGRP and anti‐CGRP receptor monoclonal antibodies since the writing of his previous review in May 2018, with an emphasis on data provided at the American Headache Society 60th Scientific Meeting, San Francisco, June 2018.… Read More...